PlainRecalls
FDA Drug Low Class III Ongoing

Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-405-60.

Reported: July 27, 2022 Initiated: June 29, 2022 #D-1282-2022

Product Description

Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-405-60.

Reason for Recall

Failed Tablet/Capsule Specification : Capsule breakage

Details

Units Affected
168936 bottles
Distribution
USA Nationwide
Location
Mahwah, NJ

Frequently Asked Questions

What product was recalled?
Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-405-60.. Recalled by Glenmark Pharmaceuticals Inc., USA. Units affected: 168936 bottles.
Why was this product recalled?
Failed Tablet/Capsule Specification : Capsule breakage
Which agency issued this recall?
This recall was issued by the FDA Drug on July 27, 2022. Severity: Low. Recall number: D-1282-2022.